Showing results (541-550 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|September 15, 2023
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in SwedenValgerdur Sigurdardottir, Anna Engstrom, Patric Berling, et al.Journal of Medical Economics|June 14, 2023
Benefits of MR-proADM-guided decision-making in the emergency department: clinical and economic evaluation in Italy, Germany, Spain, and the UKCamilla Porta, Hirad Houshmand, Massimiliano Povero, et al.Journal of Medical Economics|March 6, 2026
The indirect economic burden caused by premature mortality from lung cancer in Asia-Pacific countries; years of life lost and productivity costsManoj Gambhir, Vishnu Subash, Deepak Alexander, et al.Journal of Medical Economics|February 23, 2026
Real-world treatment switching and healthcare costs of onabotulinumtoxinA and calcitonin gene-related peptide monoclonal antibodies in Medicare patients with chronic migraine: a retrospective claims analysisYanan Dong, Ziling Mao, Annaliza Dominguez, et al.Journal of Medical Economics|February 23, 2026
Economic evaluation of perioperative pembrolizumab plus standard of care as treatment for resectable locally advanced head and neck squamous cell carcinoma in the United StatesFeng Qian, Arielle G Bensimon, Anjela Tzontcheva, et al.Journal of Medical Economics|February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United StatesAndrea Lopez, Michael Gargano, Hongbo Yang, et al.Journal of Medical Economics|March 9, 2026
Economic and clinical value of hydrolyzed collagen in the management of spine surgery wounds: a cost-effectiveness analysisVivek Mohan, Joshua E Meyers, Benjamin G Cohen, et al.Journal of Medical Economics|March 2, 2026
Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of tirzepatide versus subcutaneous semaglutide 1 mg in patients with type 2 diabetes in the UKNaresh Kanumilli, Beatrice Osumili, Jerome Evans, et al.Journal of Medical Economics|March 9, 2026
A systematic literature review of methodologies used in economic evaluations of combination vaccinesManuela Di Fusco, Shailja Vaghela, Ceu Mateus, et al.Journal of Medical Economics|February 28, 2026
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluationShaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.Pageof 241